[Federal Register: November 16, 2007 (Volume 72, Number 221)] [Notices] [Page 64677-64678] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr16no07-139] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 16, 2007, Cody Laboratories, 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Codeine (9050)............................. II Ecgonine (9180)............................ II Hydrocodone (9193)......................... II Morphine (9300)............................ II ------------------------------------------------------------------------ The company plans on manufacturing the listed controlled substances in bulk for sale to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, VA 22152; and must be filed no later than January 15, 2008. [[Page 64678]] Dated: November 6, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7-22515 Filed 11-15-07; 8:45 am] BILLING CODE 4410-09-P